A RECOMBINATION VIRUS ABLE TO SPECIFICALLY KILL TUMOR ASSOCIATED WITH EB VIRUS AND THE CONSTRUCTING METHOD THEREOF

Details for Australian Patent Application No. 2002226265 (hide)

Owner VIRGENE BIOTECHNOLOGY LIMITED

Inventors WU, Mengchao; QIAN, Qijun; CHE, Xiaoyan; SHAM, Shuntang

Pub. Number AU-A-2002226265

PCT Pub. Number WO2002/056917

Priority 01 1 05247.3 18.01.01 CN

Filing date 17 January 2002

Wipo publication date 30 July 2002

International Classifications

A61K 048/00 Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

C12N 015/86 Mutation or genetic engineering - Viral vectors

A61P 035/00 Antineoplastic agents

Event Publications

13 February 2003 Application Open to Public Inspection

  Published as AU-A-2002226265

5 February 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002226266-AMINE DERIVATIVE WITH POTASSIUM CHANNEL REGULATORY FUNCTION, ITS PREPARATION AND USE

2002226264-A SHIP